Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

12.34
Delayed Data
As of Apr 29
 -0.01 / -0.08%
Today’s Change
6.36
Today|||52-Week Range
19.96
+17.08%
Year-to-Date

Today’s Trading

Previous close12.35
Today’s open12.68
Day’s range11.95 - 13.07
Volume918,429
Average volume (3 months)739,487
Market cap$1.4B
Dividend yield8.11%
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+450.00%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...-1.03-3.73%
PRTAProthena Corporation...+0.15+0.35%
ITCIIntra-Cellular Thera...+0.03+0.09%
CXRXConcordia Healthcare...-1.40-4.58%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.12
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs